TD Cowen Reiterates Buy Rating on Upstream Bio (UPB)

February 5, 2026 5:42 AM EST Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating and {REMOVEPT} price target on Upstream Bio (NASDAQ: UPB).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login